Abstract: Plant disease detection is a critical challenge in agriculture, as undetected or poorly managed diseases can lead to significant yield losses, economic setbacks for farmers, and compromised ...
India is increasing the use of domestic fuel to more than 50 per cent at power plants designed to run on imported coal, as the world's second-largest thermal coal importer seeks to curb costly ...
Should you have feedback on this article, please complete the fields below. Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be ...
We encourage the community to contribute to this repository. If you have suggestions for new papers, resources, or improvements, please open an issue or submit a pull request.
Abstract: Background: Efficient data processing is an increasing additional important part in computer science, especially with large growing datasets. MATLAB is a complex and most often used tool ...
India is set to add 25.4 lakh tonnes of annual urea production capacity with two new fertiliser plants expected to begin operations shortly, a move the government says will strengthen domestic ...
Shares of Dabur India traded flat in Friday's trading session on June 12, even as the Indian stock market's benchmark indices rejoiced, with investors cautious following the United States Food & Drug ...
Shares of Dabur India will remain in focus on Friday after the FMCG major said that the US FDA has issued an import alert for drugs manufactured by the company at its manufacturing plant situated in ...
Shares of Dabur India Ltd. will be in focus on Friday, June 12, after the company said the US Food and Drug Administration (FDA) has placed certain products manufactured at its Silvassa facility under ...
The US Food and Drug Administration has issued an import alert for drugs manufactured at Dabur India's factory in Dadra and Nagar Haveli, following an inspection, the consumer goods company said ...
Synopsis: The US FDA has placed Dabur India’s Silvassa manufacturing facility under Import Alert 66-40 following an inspection that found falsified manufacturing records and grossly unsanitary ...
The U.S. Food and Drug Administration has issued an import alert for drugs manufactured at Dabur India's factory in India's western region of Dadra and Nagar Haveli following an inspection, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results